Kestra Medical Technologies, Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Kestra Medical Technologies, Ltd. (KMTS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 13.59 thousand shares for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-07-31 was 13.59K shares, a 87.62% decline year-over-year.
- Kestra Medical Technologies, Ltd. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-04-30 was 9.72K shares.
- Kestra Medical Technologies, Ltd. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-01-31 was 11.80K shares.
- Kestra Medical Technologies, Ltd. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-10-31 was -21.60K shares.
- Kestra Medical Technologies, Ltd. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2026 was 109.72K shares, a 1092.62% increase from fiscal 2025.
- Kestra Medical Technologies, Ltd. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 9.20K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-07-31 | 13.59K shares 10-Q · filed 2026-09-14 | 23.31K shares derived: sum of 2 quarters · filed 2026-09-14 | 35.11K shares derived: sum of 3 quarters · filed 2026-09-14 | 13.51K shares derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | 9.72K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | 21.52K shares derived: sum of 2 quarters · filed 2026-07-14 | -79.00 shares derived: sum of 3 quarters · filed 2026-07-14 | 109.72K shares 10-K · filed 2026-07-14 |
| 2026-01-31 | 11.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | -9.80K shares derived: sum of 2 quarters · filed 2026-03-17 | 100.00K shares 10-Q · filed 2026-03-17 | |
| 2025-10-31 | -21.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-11 | 88.20K shares 10-Q · filed 2025-12-11 | ||
| 2025-07-31 | 109.80K shares 10-Q · filed 2025-09-12 | |||
| 2025-04-30 | 9.20K shares 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |